Serum Ferritin Is Differentially Associated with Anti-oxidative Status and Insulin Resistance in Healthy Obese and Non-obese Women
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Ferritin is known to be associated with insulin resistance (IR) and oxidative stress; however, recent studies have shown that there is an association between ferritin and anti-oxidative status. To date, the biphasic response of ferritin to oxidative stress has not been fully evaluated. Thus, we investigated the association between ferritin and IR and anti-oxidative status in obese and non-obese women. Methods: We evaluated the homeostasis model assessment of insulin resistance (HOMA-IR) and total anti-oxidant status (TAS) in a total of 111 healthy women between the ages of 32 and 68 years. Results: In all of the study subjects, ferritin levels were positively correlated with age (r = 0.38, P < 0.001), body mass index (r = 0.24, P = 0.01), TAS (r = 0.38, P < 0.001) and HOMA-IR (r = 0.20, P = 0.04). In the subgroup analysis, ferritin levels were correlated with age (r = 0.39, P < 0.001) and TAS (r = 0.43, P < 0.001) in the non-obese group and with insulin (r = 0.50, P =0.02) and HOMA-IR (r = 0.52, P = 0.01) levels in the obese group. On stepwise multiple linear regression analysis, ferritin was found to be independently associated with TAS (B = 177.16, P < 0.0001) in the non-obese group and independently associated with HOMA-IR (B = 30.36, P = 0.01) in the obese group. Conclusion: Our findings suggest ferritin is associated with IR in obese women and with anti-oxidative status in non-obese women. Further studies are warranted to elucidate the precise role of ferritin in obesity.
Abstract
Background: Ferritin is known to be associated with insulin resistance (IR) and oxidative stress; however, recent studies have shown that there is an association between ferritin and anti-oxidative status. To date, the biphasic response of ferritin to oxidative stress has not been fully evaluated. Thus, we investigated the association between ferritin and IR and anti-oxidative status in obese and non-obese women. Methods: We evaluated the homeostasis model assessment of insulin resistance (HOMA-IR) and total anti-oxidant status (TAS) in a total of 111 healthy women between the ages of 32 and 68 years. Results: In all of the study subjects, ferritin levels were positively correlated with age (r = 0.38, P < 0.001), body mass index (r = 0.24, P = 0.01), TAS (r = 0.38, P < 0.001) and HOMA-IR (r = 0.20, P = 0.04). In the subgroup analysis, ferritin levels were correlated with age (r = 0.39, P < 0.001) and TAS (r = 0.43, P < 0.001) in the non-obese group and with insulin (r = 0.50, P =0.02) and HOMA-IR (r = 0.52, P = 0.01) levels in the obese group. On stepwise multiple linear regression analysis, ferritin was found to be independently associated with TAS (B = 177.16, P < 0.0001) in the non-obese group and independently associated with HOMA-IR (B = 30.36, P = 0.01) in the obese group. Conclusion: Our findings suggest ferritin is associated with IR in obese women and with anti-oxidative status in non-obese women. Further studies are warranted to elucidate the precise role of ferritin in obesity.
참고문헌 (29)
- Cook JD, "The quantitative assessment of body iron", Blood, 101, pp.3359~3364 (2003)
- Jung Hwan Yoon, "Oxidative modification of ferritin induced by hydrogen peroxide", BMB Reports, 44(3), pp.165~169 (2011), 생화학분자생물학회
- Galkina E, "Immune and inflammatory mechanisms of atherosclerosis (*)", Annu Rev Immunol, 27, pp.165~197 (2009)
- Galaris D, "Oxidative stress and iron homeostasis: mechanistic and health aspects", Crit Rev Clin Lab Sci, 45, pp.1~23 (2008)
- You SA, "Ferritin in atherosclerosis", Clin Chim Acta, 357, pp.1~16 (2005)
- Sun L, "Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese", J Clin Endocrinol Metab, 93, pp.4690~4696 (2008)
- Jehn M, "Serum ferritin and risk of the metabolic syndrome in U.S. adults", Diabetes Care, 27, pp.2422~2428 (2004)
- Schulpis KH, "The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children", Acta Paediatr, 99, pp.1565~1570 (2010)
- Lin F, "Hemin-enhanced resistance of human leukemia cells to oxidative killing: antisense determination of ferritin involvement", Arch Biochem Biophys, 352, pp.51~58 (1998)
- Lawson DM, "Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts", Nature, 349, pp.541~544 (1991)
- Western Pacific Regional Office of the World Health Organization, "The Asia- Pacific perspective: redefining obesity and its treatment" (2000), Health Communications Australia
- Wolff SP, "Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications", Br Med Bull, 49, pp.642~652 (1993)
- Eshed I, "Plasma ferritin and type 2 diabetes mellitus: a critical review", Endocr Res, 27, pp.91~97 (2001)
- Fernandez-Real JM, "Cross-talk between iron metabolism and diabetes", Diabetes, 51, pp.2348~2354 (2002)
- Balla G, "Ferritin: a cytoprotective antioxidant strategem of endothelium", J Biol Chem, 267, pp.18148~18153 (1992)
- Lee M, "Identification of the EPR-active iron-nitrosyl complexes in mammalian ferritins", Biochemistry, 33, pp.3679~3687 (1994)
- Cozzi A, "Iron detoxifying activity of ferritin: effects of H and L human apoferritins on lipid peroxidation in vitro", FEBS Lett, 277, pp.119~122 (1990)
- Re R, "Antioxidant activity applying an improved ABTS radical cation decolorization assay", Free Radic Biol Med, 26, pp.1231~1237 (1999)
- Sheu WH, "relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men", Clin Endocrinol (Oxf), 58, pp.380~385 (2003)
- Lantos J, "Monitoring of plasma total antioxidant status in di´erent diseases", Acta Chir Hung, 36, pp.188~189 (1997)
- Zawadzka-Bartczak E, "Activities of red blood cell antioxidative enzymes (SOD, GPx) and total anti-oxidative capacity of serum (TAS) in men with coronary atherosclerosis and in healthy pilots", Med Sci Monit, 11, pp.CR440~CR444 (2005)
- Kuklinska AM, "High-sensitivity C-reactive protein and total antioxidant status in patients with essential arterial hypertension and dyslipidemia", Adv Med Sci, 54, pp.225~232 (2009)
- Subash P, "Total antioxidant status and oxidative DNA damage in a South Indian population of essential hypertensives", J Hum Hypertens, 24, pp.475~482 (2010)
- Pandzic Jaksic V, "Adipocytokines as mediators of metabolic role of adipose tissue", Acta Med Croatica, 64, pp.253~262 (2010)
- Wajchenberg BL, "Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome", Endocr Rev, 21, pp.697~738 (2000)
- Ikegami Y, "Adiponectin upregulates ferritin heavy chain in skeletal muscle cells", Diabetes, 58, pp.61~70 (2009)
- Im JA, "Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults", Metabolism, 55, pp.1546~1550 (2006)
- Matsuzawa Y, "Adiponectin and metabolic syndrome", Arterioscler Thromb Vasc Biol, 24, pp.29~33 (2004)
- Halle M, "Low-grade systemic inflammation in overweight children: impact of physical fitness", Exerc Immunol Rev, 10, pp.66~74 (2004)